Xiaohui Luan
No. 301 Yan Chang Zhong Road
Shanghai, 200072, China
Shanghai, 200072, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
An integrative multi-omics landscape of multi-dimensional cellular stress and metabolic reprogramming in melanoma treated with targeted alpha therapy.
Journal: Journal of nanobiotechnology
Published: March 27, 2026
Targeted alpha therapy: a comprehensive analysis of the biological effects from "local-regional-systemic" dimensions.
Journal: European journal of nuclear medicine and molecular imaging
Published: April 29, 2025
Monitoring Sorafenib Resistance and Efficacy in Hepatocellular Carcinoma Using [18F]Alfatide II and [18F]Fluorodeoxyglucose Positron Emission Tomography.
Journal: Molecular pharmaceutics
Published: February 24, 2025
Preclinical evaluation of [211At]At-AuNP-ABDMPL16 for targeted alpha therapy in Melanoma.
Journal: European journal of nuclear medicine and molecular imaging
Published: January 21, 2025
Real-time diagnosis of sampled lesions in targeted biopsy of prostate Cancer using a novel tracer [64Cu] Cu-DOTA-PSMA-3Q: a pilot preclinical study.
Journal: European journal of nuclear medicine and molecular imaging
Published: August 30, 2024
Layered Double Hydroxides for Radium-223 Targeted Alpha Therapy with Elicitation of the Immune Response.
Journal: Advanced healthcare materials
Published: August 25, 2024
The first-in-human preclinical evaluation of the new probe [123I]I-PSMA-7 for real-time intraoperative targeted biopsy and SPECT/CT imaging in prostate cancer.
Journal: European journal of nuclear medicine and molecular imaging
Published: March 25, 2024
Metabolic parameters of pretreatment 2-[18F]fluoro-D-glucose positron emission tomography for prognosis in patients with gallbladder adenocarcinoma: a cohort study.
Journal: Quantitative imaging in medicine and surgery
Published: July 12, 2023
Corrigendum: The role of 18F-FDG PET in predicting the pathological response and prognosis to unresectable HCC patients treated with lenvatinib and PD-1 inhibitors as a conversion therapy.
Journal: Frontiers in immunology
Published: May 09, 2023
The role of 18F-FDG PET in predicting the pathological response and prognosis to unresectable HCC patients treated with lenvatinib and PD-1 inhibitors as a conversion therapy.
Journal: Frontiers in immunology
Published: January 27, 2023
Multiparameter diagnostic model based on 18F-FDG positron emission tomography and serological examination for differentiating focal autoimmune pancreatitis from pancreatic ductal adenocarcinoma.
Journal: Quantitative imaging in medicine and surgery
Published: January 19, 2023
Can 18F-PSMA-7Q PET/CT replace prostate biopsy for the diagnosis of prostate cancer?-A single-center retrospective study.
Journal: Translational andrology and urology
Published: November 21, 2022
Last Updated: 09/26/2026